|
|
Volumn 332, Issue 6031, 2011, Pages 784-789
|
|
The emerging race to cure HIV infections
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;
CHEMOKINE RECEPTOR CCR5;
DISULFIRAM;
VORINOSTAT;
ZIDOVUDINE;
ZINC FINGER PROTEIN;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
DRUG;
HUMAN IMMUNODEFICIENCY VIRUS;
IMMUNE SYSTEM;
INFECTIOUS DISEASE;
RESEARCH WORK;
RESERVOIR;
VIRUS;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
ACUTE GRANULOCYTIC LEUKEMIA;
APHERESIS;
CD4 LYMPHOCYTE COUNT;
CLINICAL RESEARCH;
EPIDEMIC;
EXTRAPULMONARY TUBERCULOSIS;
HIGHLY ACTIVE ANTIRETROVIRAL THERAPY;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
INFECTION RESISTANCE;
LEUKEMIA RELAPSE;
NONHUMAN;
NONVIRAL GENE THERAPY;
OPPORTUNISTIC INFECTION;
PRIORITY JOURNAL;
SHORT SURVEY;
UNSAFE SEX;
VIRUS LOAD;
ANTI-HIV AGENTS;
ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE;
CD4-POSITIVE T-LYMPHOCYTES;
CLINICAL TRIALS AS TOPIC;
GENE THERAPY;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
HIV;
HIV INFECTIONS;
HUMANS;
MALE;
RECEPTORS, CCR5;
TRANSCRIPTION, GENETIC;
VIRUS LATENCY;
PHLEUM PRATENSE;
|
|
EID: 79956049416
PISSN: 00368075
EISSN: 10959203
Source Type: Journal
DOI: 10.1126/science.332.6031.784 Document Type: Short Survey |
|
Times cited : (29)
|
|
References (0)
|
